Moderna says construction of its new mRNA vaccine factory in the Montreal area will begin later this year, with production expected to begin by the end of 2024.
The vaccine manufacturer is announcing that it has agreed to purchase land in a biotechnology park in Laval, Que., a northern suburb of Montreal, to serve as the site of its biomanufacturing facility.
The Massachusetts-based company says the site is ideal due to its proximity to a renowned research institute, the Institut national de la recherche scientifique.
Moderna announced in April that it would build a factory in the Montreal area that would be able to produce 100 million doses of mRNA vaccines a year….